SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056805
Filing Date
2021-11-15
Accepted
2021-11-15 07:05:52
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20210930.htm   iXBRL 10-Q 2695231
2 EX-10.1 logc-ex101_66.htm EX-10.1 119772
3 EX-10.2 logc-ex102_65.htm EX-10.2 21698
4 EX-31.1 logc-ex311_12.htm EX-31.1 18756
5 EX-31.2 logc-ex312_14.htm EX-31.2 18497
6 EX-32.1 logc-ex321_10.htm EX-32.1 7618
  Complete submission text file 0001564590-21-056805.txt   7333315

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA logc-20210930.xsd EX-101.SCH 40751
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20210930_cal.xml EX-101.CAL 47423
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20210930_def.xml EX-101.DEF 111419
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20210930_lab.xml EX-101.LAB 335245
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20210930_pre.xml EX-101.PRE 245440
12 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20210930_htm.xml XML 1010647
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 211406255
SIC: 2836 Biological Products, (No Diagnostic Substances)